FDA Approved: CORLANOR — Supplemental Application (Amgen Inc)

View source ↗

Summary

The FDA approved a supplemental application for CORLANOR (ivabradine) from Amgen Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Corlanor (ivabradine)

Snippet

SUPPL AP for CORLANOR (IVABRADINE)